• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异氟醚预处理通过抑制 miR-195-3p 的表达减轻缺氧/复氧诱导的心肌细胞损伤。

Isoflurane Preconditioning Alleviates Hypoxia/Reoxygenation-Induced Cardiomyocyte Injury by Inhibiting miR-195-3p Expression.

机构信息

Department of Anesthesiology, Beijing Stomatological Hospital Affiliated to Capital Medical University, Beijing, 100050, China.

Department of Anesthesiology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, 250014, China.

出版信息

Cardiovasc Toxicol. 2024 Jul;24(7):637-645. doi: 10.1007/s12012-024-09869-y. Epub 2024 May 8.

DOI:10.1007/s12012-024-09869-y
PMID:38720121
Abstract

To investigate the role of microRNA-195-3p (miR-195-3p) in hypoxia/reoxygenation (H/R)-induced cardiomyocyte injury. AC16 human cardiomyocyte cells were cultured and pretreated with different concentrations of isoflurane (ISO) (1%, 2%, and 3%), followed by 6 h each of hypoxia and reoxygenation to construct H/R cell models. The optimum ISO concentration was assessed based on the cell viability. miR-195-3p expression was regulated by in vitro cell transfection. Cell viability was determined by MTT assay, and apoptosis was evaluated by flow cytometry. The levels of myocardial injury and inflammation were determined by enzyme-linked immunosorbent assay. Compared with the control group, the cell viability of the H/R group had significantly decreased and that of ISO pretreatment had increased in a dose-dependent manner. Therefore, we selected a 2% ISO concentration for pretreatment. MiR-195-3p expression had significantly increased in the H/R group and decreased after 2% ISO pretreatment. Additionally, the number of apoptotic cells and the levels of lactate dehydrogenase, creatine kinase-myoglobin binding, cardiac troponin I, interleukin (IL)-1β, IL-6, and tumor necrosis factor-α had increased significantly. ISO preconditioning inhibited H/R-induced AC16 cell damage, whereas miR-195-3p overexpression reversed the protective effects of ISO on cardiomyocytes. The expression of phosphatase and tensin homolog deleted on chromosome 10 (PTEN) was reduced in the H/R-induced AC16 cells, and PTEN is a downstream target gene of miR-195-3p. Preconditioning with 2% ISO plays a protective role in H/R-induced AC16 cell damage by inhibiting miR-195-3p expression.

摘要

目的

探讨微小 RNA-195-3p(miR-195-3p)在缺氧/复氧(H/R)诱导的心肌细胞损伤中的作用。

方法

培养 AC16 人心肌细胞,用不同浓度的异氟醚(ISO)(1%、2%和 3%)预处理,然后进行 6 h 缺氧和复氧,构建 H/R 细胞模型。根据细胞活力评估最佳 ISO 浓度。通过体外细胞转染调节 miR-195-3p 的表达。通过 MTT 测定法测定细胞活力,通过流式细胞术评估细胞凋亡。通过酶联免疫吸附试验测定心肌损伤和炎症水平。

结果

与对照组相比,H/R 组细胞活力明显下降,ISO 预处理呈剂量依赖性增加。因此,我们选择 2% ISO 浓度进行预处理。H/R 组 miR-195-3p 表达明显增加,2% ISO 预处理后表达降低。此外,凋亡细胞数和乳酸脱氢酶、肌红蛋白结合肌酸激酶、心肌肌钙蛋白 I、白细胞介素(IL)-1β、IL-6 和肿瘤坏死因子-α水平明显升高。ISO 预处理抑制 H/R 诱导的 AC16 细胞损伤,而过表达 miR-195-3p 则逆转 ISO 对心肌细胞的保护作用。在 H/R 诱导的 AC16 细胞中,磷酸酶和张力蛋白同源物缺失的染色体 10(PTEN)表达减少,PTEN 是 miR-195-3p 的下游靶基因。用 2% ISO 预处理通过抑制 miR-195-3p 的表达对 H/R 诱导的 AC16 细胞损伤起保护作用。

相似文献

1
Isoflurane Preconditioning Alleviates Hypoxia/Reoxygenation-Induced Cardiomyocyte Injury by Inhibiting miR-195-3p Expression.异氟醚预处理通过抑制 miR-195-3p 的表达减轻缺氧/复氧诱导的心肌细胞损伤。
Cardiovasc Toxicol. 2024 Jul;24(7):637-645. doi: 10.1007/s12012-024-09869-y. Epub 2024 May 8.
2
miR-652-3p Suppressed the Protective Effects of Isoflurane Against Myocardial Injury in Hypoxia/Reoxygenation by Targeting ISL1.miR-652-3p 通过靶向 ISL1 抑制异氟醚对缺氧/复氧心肌损伤的保护作用。
Cardiovasc Toxicol. 2024 Jul;24(7):646-655. doi: 10.1007/s12012-024-09870-5. Epub 2024 May 27.
3
Isoflurane Preconditioning May Attenuate Cardiomyocyte Injury Induced by Hypoxia/Reoxygenation Possibly by Regulating miR-363-3p.异氟醚预处理可能通过调节 miR-363-3p 减轻缺氧/复氧诱导的心肌细胞损伤。
Neurotox Res. 2022 Dec;40(6):1895-1901. doi: 10.1007/s12640-022-00584-6. Epub 2022 Oct 12.
4
Isoflurane pretreatment protects against myocardial ischemia/reperfusion injury via mediating lncRNA CASC15/miR-542-3p axis.异氟醚预处理通过介导 lncRNA CASC15/miR-542-3p 轴保护心肌缺血/再灌注损伤。
Toxicol Mech Methods. 2024 Jul;34(6):694-702. doi: 10.1080/15376516.2024.2327057. Epub 2024 Apr 4.
5
Isoflurane Alleviates Myocardial Injury Induced by Hypoxia/Reoxygenation by Regulating miR-18a-5p.异氟醚通过调节 miR-18a-5p 缓解缺氧/复氧诱导的心肌损伤。
Cardiovasc Toxicol. 2021 Oct;21(10):800-807. doi: 10.1007/s12012-021-09670-1. Epub 2021 Jun 28.
6
The Preconditioning with Sevoflurane Alleviates Hypoxia-Reoxygenation-Induced Myocardial Cell Injury by Regulating the lncRNA LINC00265/miR-370-3p Axis.七氟醚预处理通过调控lncRNA LINC00265/miR-370-3p轴减轻缺氧复氧诱导的心肌细胞损伤。
Cardiovasc Toxicol. 2025 May;25(5):778-789. doi: 10.1007/s12012-025-09984-4. Epub 2025 Mar 20.
7
Isoflurane preconditioning attenuates OGD/R-induced cardiomyocyte cytotoxicity by regulating the miR-210/BNIP3 axis.异氟醚预处理通过调节 miR-210/BNIP3 轴减轻 OGD/R 诱导的心肌细胞毒性。
J Appl Toxicol. 2024 Nov;44(11):1761-1772. doi: 10.1002/jat.4674. Epub 2024 Jul 20.
8
lncRNA CCAT2 Protects Against Cardiomyocyte Injury After Myocardial Ischemia/Reperfusion by Regulating BMI1 Expression.长链非编码 RNA CCAT2 通过调控 BMI1 表达减轻心肌缺血/再灌注损伤。
Int Heart J. 2024;65(2):279-291. doi: 10.1536/ihj.23-569.
9
Sevoflurane protects cardiomyocytes against hypoxia/reperfusion injury via LINC01133/miR-30a-5p axis.七氟醚通过 LINC01133/miR-30a-5p 轴保护心肌细胞免受缺氧/再灌注损伤。
Biosci Rep. 2020 Dec 23;40(12). doi: 10.1042/BSR20200713.
10
Disruption of BACH1 Protects AC16 Cardiomyocytes Against Hypoxia/Reoxygenation-Evoked Injury by Diminishing CDKN3 Transcription.BACH1 缺失通过降低 CDKN3 转录来保护 AC16 心肌细胞免受低氧/复氧损伤。
Cardiovasc Toxicol. 2024 Oct;24(10):1105-1115. doi: 10.1007/s12012-024-09900-2. Epub 2024 Jul 26.

本文引用的文献

1
Inhibition of miR-195-3p protects against cardiac dysfunction and fibrosis after myocardial infarction.抑制 miR-195-3p 可预防心肌梗死后的心功能障碍和纤维化。
Int J Cardiol. 2023 Sep 15;387:131128. doi: 10.1016/j.ijcard.2023.131128. Epub 2023 Jun 24.
2
miR-195-3p/BDNF axis regulates hypoxic injury by targeting P-ERK1/2 expression.miR-195-3p/BDNF 轴通过靶向 P-ERK1/2 表达来调节缺氧损伤。
Medicine (Baltimore). 2022 Nov 18;101(46):e31586. doi: 10.1097/MD.0000000000031586.
3
Intersection of the Ubiquitin-Proteasome System with Oxidative Stress in Cardiovascular Disease.
泛素-蛋白酶体系统与心血管疾病中氧化应激的交汇。
Int J Mol Sci. 2022 Oct 13;23(20):12197. doi: 10.3390/ijms232012197.
4
The Protective Effect of Interval Exercise on Myocardial Ischemia-Reperfusion Injury in Players.间歇运动对运动员心肌缺血再灌注损伤的保护作用。
Biomed Res Int. 2022 Aug 8;2022:4353340. doi: 10.1155/2022/4353340. eCollection 2022.
5
Juglone from Walnut Produces Cardioprotective Effects against Isoproterenol-Induced Myocardial Injury in SD Rats.核桃中的胡桃醌对异丙肾上腺素诱导的SD大鼠心肌损伤具有心脏保护作用。
Curr Issues Mol Biol. 2022 Jul 16;44(7):3180-3193. doi: 10.3390/cimb44070220.
6
Ferroptosis-Specific Inhibitor Ferrostatin-1 Relieves HO-Induced Redox Imbalance in Primary Cardiomyocytes through the Nrf2/ARE Pathway.铁死亡特异性抑制剂 Ferrostatin-1 通过 Nrf2/ARE 通路缓解 HO 诱导的原代心肌细胞氧化还原失衡。
Dis Markers. 2022 Feb 22;2022:4539932. doi: 10.1155/2022/4539932. eCollection 2022.
7
Recent progress (2015-2020) in the investigation of the pharmacological effects and mechanisms of ginsenoside Rb, a main active ingredient in Meyer.人参皂苷Rb是迈耶的主要活性成分,其药理作用及机制研究的近期进展(2015 - 2020年)
J Ginseng Res. 2022 Jan;46(1):39-53. doi: 10.1016/j.jgr.2021.07.008. Epub 2021 Jul 30.
8
Long Non-Coding RNAs in Diffuse Large B-Cell Lymphoma.弥漫性大B细胞淋巴瘤中的长链非编码RNA
Noncoding RNA. 2020 Dec 28;7(1):1. doi: 10.3390/ncrna7010001.
9
Effect of Composite Nanoparticle CeO₂ on Myocardial Ischemic Re-Infusion of Cardio Myocyte Apoptosis in Mouse.复合纳米粒子 CeO₂ 对心肌缺血再灌注损伤诱导的心肌细胞凋亡的影响。
J Nanosci Nanotechnol. 2021 Feb 1;21(2):1397-1402. doi: 10.1166/jnn.2021.18643.
10
PTEN-mediated mitophagy and APE1 overexpression protects against cardiac hypoxia/reoxygenation injury.PTEN 介导的线粒体自噬和 APE1 过表达可防止心脏缺氧/复氧损伤。
In Vitro Cell Dev Biol Anim. 2019 Oct;55(9):741-748. doi: 10.1007/s11626-019-00389-6. Epub 2019 Aug 20.